Showing 8581-8590 of 9287 results for "".
- Sciton Targets Veins, Skin, and Hair with Clear Suitehttps://practicaldermatology.com/news/sciton-targets-veins-skin-and-hair-with-clear-suite/2460111/Sciton Inc. is launching its Clear Suite family of products. The Clear Suite offerings make the JOULE platform customizable. Utilizing the 1064 Nd:YAG wavelength, the Clear Suite family of products, including ClearV, ClearSilk, and ClearHair, combined with BroadBand Light (BBL), al
- Highlights from Day 3 at DERM2019: Hyperhidrosis, Bug Bites, Sunscreen, and Morehttps://practicaldermatology.com/news/highlights-from-day-3-at-derm2019-hyperhidrosis-bug-bites-sunscreen-and-more/2460101/As the nation observed the 50th anniversary of the Apollo 11 lunar landing, the day the famous quote from astronaut Neil Armstrong was spoken “That’s one small step for a man, one giant leap for mankind," DERM2019 organziers say the shot for the stars with their faculty were not
- Proof of Concept Study Supports Dermata’s Topical Delivery Mechanism for Botulinum Toxinhttps://practicaldermatology.com/news/proof-of-concept-study-supports-dermatas-topical-delivery-mechanism-for-botulinum-toxin/2460089/Dermata Therapeutics’ DMT410 (DMT310 + botulinum toxin) performed well in a Phase 1proof of concept study for the treatment of primary axillary hyperhidrosis, the Company reports. DMT410 is a combination regimen for the treatment of skin
- Hair Loss Breakthrough: 3D-Printing Creates “Hair Farms”https://practicaldermatology.com/news/hair-loss-breakthrough-research-uses-3d-printing-to-create-hair-farms/2460083/Columbia researchers have created a way to use 3-D printing to create “hair farms” in a dish, which could open up hair restoration surgery to more people, including women, and improve the way pharmaceutical companies search for new hair growth drugs. The findings, which appe
- Duobrii Lotion for Plaque Psoriasis Hits Shelveshttps://practicaldermatology.com/news/duobrii-lotion-for-plaque-psoriasis-hits-shelves/2460079/Ortho Dermatologics’ Duobrii (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%, is now available. Approved by the U.S. Food and Drug Administration on April 25, 2019, Duobrii is the first and only topical lotion that contains a uniq
- Gillette Skin Guard Reduces Razor Bumps by 60%https://practicaldermatology.com/news/gillette-skin-guard-reduces-razor-bumps-by-60/2460065/Gillette’s recently launched SkinGuard razor is helping men who are susceptible to razor bumps, also known as Pseudofolliculitis barbae or PFB, new research shows. Results from a recent clinical study from Wake Forest University revealed that the incidence of men’
- Registration Open for Skin of Color Update Meetinghttps://practicaldermatology.com/news/registration-open-for-skin-of-color-update-meeting/2460060/The medical education event focused on the dermatologic treatment of skin of color has a new name. Skin of Color Update, previously the Skin of Color Seminar Series, provides dermatologists with evidence-based research and practical pearls in treating skin of color, including patients with multir
- Sciton Promotes Two Leadershttps://practicaldermatology.com/news/sciton-promotes-two-leaders/2460050/Bryant Wong is the new Vice President of Finance at Sciton and Emma Haaland is the new Global Director of Customer Service. Mr. Wong spent two years as the leader of the finance department at Sciton. He worked for nearly 12 years with PricewaterhouseCoopers and Deloitte C
- Soliton Takes On Cellulitehttps://practicaldermatology.com/news/soliton-takes-on-cellulite-2/2460049/Soliton, Inc.’s Rapid Acoustic Pulse ("RAP") device may selectively disrupt of the fibrotic septa that contribute to the appearance of cellulite, according to preclinical studies. The device is cleated for use in tattoo removal, howe
- New NRS Study Shows Positive Impact of Clear Skin in Rosacea Patientshttps://practicaldermatology.com/news/new-nrs-study-shows-positive-impact-of-clear-skin-in-rosacea-patients/2460048/Treating rosacea can have a major positive impact on patients’ lives, according to a new survey by the National Rosacea Society. In the survey of 1,044 rosacea patients, around 76 percent of all respondents saw at least some improvement in th